SC

Surekha Chary Madabhushini

Active Director Director DIN 00005572
DIN 00005572 First appointment Sep 2005 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Sep 2005
Shareholding value •••• Premium profile

About Surekha Chary Madabhushini

Data last updated:

Surekha Chary Madabhushini is a Director at Charys Investments Private Limited (since 2005), Director at Concept Industries Private Limited (since 2018) and Director at Magene Research Foundation (since 2008). The companies operate in Financial Services, Agriculture and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹6.29 Cr; the largest is Charys Investments Private Limited at ₹5.86 Cr (FY 2025). Earlier, Surekha Chary Madabhushini was a Director at Elbit Medical Diagnostics Private Limited (2006–2016) and Director at Magene Life Sciences Private Limited (from 2017) and 1 more.

DIN 00005572
Primary Designation Director
Industry Financial Services
First Appointment 26 Sep 2005
Oldest Company Age 37 yrs
Largest company Charys Investments Private Limited · ₹5.86 Cr (FY 2025)
Combined revenue ₹6.29 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Charys Investments Private Limited U65993TG1988PTC009206
Director26 Sep 20051988₹5.86 Cr (FY 2025)Active
Concept Industries Private Limited U15499TG1993PTC015943
Director16 Apr 20181993₹42.7 Lakh (FY 2022)Active
Magene Research Foundation U01122TG1998NPL029019
Director02 Feb 20081998Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Aug 20061995₹8.98 Cr (FY 2024)Active
Magene Life Sciences Private Limited U24231TG2002PTC038939
Director04 Sep 20172002Strike Off
Director08 Jan 20072002Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Magene Research Foundation
Concept Industries Private Limited
Magene Life Sciences Private Limited
Charys Investments Private Limited
Premium access

Shareholding and investment profile for Surekha Chary Madabhushini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surekha Chary Madabhushini

Surekha Chary Madabhushini currently holds 3 directorships: Charys Investments Private Limited (Director, since 26 Sep 2005, revenue ₹5.86 Cr (FY 2025)); Concept Industries Private Limited (Director, since 16 Apr 2018, revenue ₹42.7 Lakh (FY 2022)); Magene Research Foundation (Director, since 02 Feb 2008).

Surekha Chary Madabhushini was first appointed on 26 Sep 2005 as Director at Charys Investments Private Limited. The most recent appointment on record is 16 Apr 2018 at Concept Industries Private Limited.

The 2 current companies of Surekha Chary Madabhushini that report revenue have a combined latest revenue of ₹6.29 Cr: Charys Investments Private Limited ₹5.86 Cr (FY 2025); Concept Industries Private Limited ₹42.7 Lakh (FY 2022).

Surekha Chary Madabhushini held 3 earlier board appointments: Elbit Medical Diagnostics Private Limited (Director, 03 Aug 2006 to 31 Mar 2016); Magene Life Sciences Private Limited (Director, from 04 Sep 2017); Charys Finance & Securities Private Limited (Director, from 08 Jan 2007).

The current boards of Surekha Chary Madabhushini's companies include Anantha Madabhushini Chary (Charys Investments Private Limited), Venkata Madabhushini Sumanth (Charys Investments Private Limited), Narahari Desika Chary Kandala (Concept Industries Private Limited), Chowdari Bapaiah Kolli (Magene Research Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available